Evidence map›Paper›PMID 27865566›Full record

Trial reportAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

Alex R Chang, Edgar R Miller, Cheryl A Anderson, Stephen P Juraschek, Melissa Moser, Karen White, Bobbie Henry, Caitlin Krekel, Susan Oh, Jeanne Charleston and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Diet and Chronic Kidney Disease.Advances in nutrition (Bethesda, Md.) · 2019
    Review
  13. Strategies for Phosphate Control in Patients With CKD.Kidney international reports · 2019
    Review
  14. Article
  15. Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study.International journal of environmental research and public health · 2018
    Article
  16. Article
  17. Dietary Phosphorus Intake and the Kidney.Annual review of nutrition · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alex R ChangGeisinger Health System, Division of Nephrology, Danville, PA. Electronic address: achang@geisinger.edu.
Edgar R MillerWelch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD; Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD.
Cheryl A AndersonDepartment of Family and Preventive Medicine, University of California, San Diego, CA.
Stephen P JuraschekDivision of General Internal Medicine, Johns Hopkins University, Baltimore, MD.
Melissa MoserInstitute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD.
Karen WhiteWelch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD.
Bobbie HenryInstitute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD.
Caitlin KrekelInstitute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD.
Susan OhInstitute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD.
Jeanne CharlestonWelch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD; Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD.
Lawrence J AppelWelch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD; Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD.
Johns Hopkins University · USGeisinger Health System · USUniversity of California, San Diego · US

Funding

Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2005 to 2019
$17.3M
RENAL DISEASE EPIDEMIOLOGY TRAINING GRANTT32DK007732 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CREWS, DEIDRA CANDICE · 1995 to 2024
$7.7M
Morbid Obesity, Bariatric Surgery, and Kidney FunctionK23DK106515 · NIDDK · GEISINGER CLINIC · PI CHANG, ALEXANDER R · 2015 to 2019
$890k
NIDDK NIH HHS K23 DK106515NIDDK NIH HHS P30 DK072488NIDDK NIH HHS T32 DK007732
6 · The paper itself

Abstract

backgroundLittle is known about the effects of phosphorus additives on patients with kidney disease. STUDY

designRandomized, double-blind, crossover trial. SETTING &

participants31 adults with early stages of presumed chronic kidney disease (estimated glomerular filtration rate ≥ 45mL/min/1.73m

interventionHigher versus lower phosphorus intake for 3 weeks. Higher phosphorus intake was achieved by the addition of commercially available diet beverages and breakfast bars to diet. OUTCOMES: Change in 24-hour urine albumin excretion and plasma fibroblast growth factor 23 level. MEASUREMENTS: Two 24-hour urine collections and a single fasting blood draw at the end of each period.

resultsMean baseline values for phosphorus intake, 24-hour urine phosphorus excretion, and estimated glomerular filtration rate were 1,113±549 (SD) mg/d, 688±300mg/d, and 74.6±22.0mL/min/1.73m LIMITATIONS: Small sample size, short duration of intervention, changes in background diet during the intervention.

conclusionsA 3-week consumption of higher phosphorus food additives did not significantly increase albuminuria. Further studies are needed to confirm these results.

Indexed as

Dietary SupplementsAgedAlbuminuriaCross-Over StudiesDouble-Blind MethodFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHumansMaleMiddle AgedPhosphorus, DietaryRenal Insufficiency, ChronicSeverity of Illness IndexFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsPhosphorus, Dietaryalbuminuriachronic kidney disease (CKD)dietfibroblast growth factor 23 (FGF-23)modifiable risk factornutritionparathyroid hormone (PTH)phosphatePhosphorus intakeproteinuriarandomized controlled trialurine albumin excretion

Identifiers

PMID27865566
PMCPMC5263092
OpenAlexW2549451639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.